Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
377 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00090363 | ZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA) | completed | Phase 2 | 447 | AstraZenecaINDUSTRY | 14 | Jan 8, 2013 | clinicaltrials |
| NCT00610714 | AZD0530 Phase II Study in Patients With Advanced Ovarian Cancer(OVERT-1) | completed | Phase 2 | 211 | AstraZenecaINDUSTRY | 12 | Dec 18, 2012 | clinicaltrials |
| NCT00014625 | E7070 in Treating Patients With Stage IV Melanoma | completed | Phase 2 | 28 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 24, 2012 | clinicaltrials |
| NCT00003989 | ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma | completed | Phase 2 | 50 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 11, 2012 | clinicaltrials |
| NCT00002903 | Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer | completed | Phase 2 | 25 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 14 | Jul 2, 2012 | clinicaltrials |
| NCT00002916 | Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer | completed | Phase 2 | 44 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Jul 2, 2012 | clinicaltrials |
| NCT00514475 | Zevalin-BEAM/BEAC With Autologous Stem Cell Support as Consolidation in First Line Treatment of Mantle Cell Lymphoma | completed | Phase 2 | 160 | Oslo University HospitalOTHER | 1 | May 4, 2012 | clinicaltrials |
| NCT00003643 | Combination Chemotherapy in Treating Men With Germ Cell Cancer | unknown | Phase 2 / Phase 3 | 498 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 14 | Mar 6, 2012 | clinicaltrials |
| NCT00101660 | Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib | completed | Phase 2 | 387 | Bristol-Myers SquibbINDUSTRY | 22 | Mar 2, 2012 | clinicaltrials |
| NCT00821912 | TaxXel: Taxotere and Xeloda in Esophageal Cancer(TaxXel) | unknown | Phase 1 / Phase 2 | 93 | Karolinska University HospitalOTHER | 2 | Feb 28, 2012 | clinicaltrials |
| NCT00913198 | A Study of CP-4126 in Patients With Advanced Pancreatic Cancer | completed | Phase 2 | 21 | Clavis PharmaINDUSTRY | 2 | Feb 10, 2012 | clinicaltrials |
| NCT00791947 | A Nordic Phase II Study of PTCL Based on Dose-intensive Induction and High-dose Consolidation With ASCT | completed | Phase 2 | 166 | University of AarhusOTHER | 3 | Sep 8, 2011 | clinicaltrials |
| NCT00101647 | Study of Dasatinib (BMS-354825) in Patients With Accelerated Phase Chronic Myeloid Leukemia | completed | Phase 2 | 197 | Bristol-Myers SquibbINDUSTRY | 23 | Apr 15, 2011 | clinicaltrials |
| NCT00101595 | Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia | completed | Phase 2 | 96 | Bristol-Myers SquibbINDUSTRY | 20 | Apr 14, 2011 | clinicaltrials |
| NCT00239343 | Phase II Trial of Preoperative Therapy With Gefitinib and Chemotherapy in Patients With ERneg Breast Cancer | completed | Phase 2 | 160 | AstraZenecaINDUSTRY | 3 | Jan 27, 2011 | clinicaltrials |
| NCT00319787 | Combination Casodex® and Iressa™ in Locally Advanced Prostate Cancer | completed | Phase 2 | 102 | AstraZenecaINDUSTRY | 1 | Jan 25, 2011 | clinicaltrials |
| NCT00357110 | Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast Cancer(@FAME) | completed | Phase 2 | 13 | AstraZenecaINDUSTRY | 3 | Dec 21, 2010 | clinicaltrials |
| NCT00369018 | A Dose-finding Study of MAL and HAL Photodynamic Therapy of Cervical Premalignant Lesions. | completed | Phase 1 / Phase 2 | 96 | PhotocureINDUSTRY | 2 | Nov 30, 2010 | clinicaltrials |
| NCT00101816 | Dasatinib (BMS-354825) in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate | completed | Phase 2 | 124 | Bristol-Myers SquibbINDUSTRY | 20 | Aug 10, 2010 | clinicaltrials |
| NCT00103844 | Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia | completed | Phase 2 | 150 | Bristol-Myers SquibbINDUSTRY | 32 | Aug 10, 2010 | clinicaltrials |
| NCT00508209 | Bortezomib and High-dose Melphalan at Myeloma Relapse | unknown | Phase 2 | 50 | Nordic Myeloma Study GroupOTHER | 3 | Jun 22, 2010 | clinicaltrials |
| NCT00533364 | Effect of SBG in Patients With Breast Cancer | completed | Phase 1 / Phase 2 | 11 | Biotec Pharmacon ASAINDUSTRY | 1 | Feb 18, 2010 | clinicaltrials |
| NCT00546039 | Synthetic Genistein (BONISTEIN™) in Patients Who Are Undergoing Surgery for Prostate Cancer | unknown | Phase 2 | 47 | University Hospital, AkerOTHER | 1 | Sep 30, 2008 | clinicaltrials |
| NCT00455416 | Dietary Intervention in Follicular Lymphoma(KLYMF) | unknown | Phase 2 | 45 | Oslo University HospitalOTHER | 1 | May 21, 2008 | clinicaltrials |
| NCT00201435 | Weekly Taxol Plus Xeloda® vs Taxotere q3wk Plus Xeloda® in the Treatment of Metastatic BC | completed | Phase 2 / Phase 3 | 224 | Norwegian Breast Cancer GroupOTHER | 1 | May 20, 2008 | clinicaltrials |
| NCT00319618 | Combination Weekly Taxotere™ With Iressa™ /Placebo in Metastatic Breast Cancer | completed | Phase 2 | 66 | AstraZenecaINDUSTRY | 1 | Dec 18, 2007 | clinicaltrials |
| NCT00232726 | Clinical Study of Previously Untreated Patients With Malignant Melanoma | completed | Phase 2 | 42 | Clavis PharmaINDUSTRY | 3 | Jul 10, 2007 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials